St. Francis Cancer Center | St. Francis Cancer Center | Novartis Signature CPDR001X2201
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1366
clinical-trial-template-default,single,single-clinical-trial,postid-1366,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.7,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

Novartis Signature CPDR001X2201

A phase II, open-label, randomized controlled study of PDR001 in patients with moderately differentiated/undifferentiated locally advanced recurrent or metastatic nasopharyngeal carcinoma who progressed on standard treatment. Read more>

« Available Clinical Trials